Intellia Therapeutics Inc (NTLA)
$12.47 -5.74% Close Oct 30, 2026 Live
Intellia Therapeutics stock today
Intellia Therapeutics closed at $12.47 on October 30, 2026, down 5.74% on the day. Over the past year it returned +1.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.74 billion.
$10.00$15.00
NovJan 2026MarMayJulSep
| Period | NTLA | S&P 500 (SPY) |
|---|---|---|
| 1 month | +3.4% | -0.9% |
| 3 months | +12.4% | +2.1% |
| Year to date | +38.7% | +11.7% |
| 1 year | +1.7% | +12.4% |
| 3 years | -47.7% | +88.5% |
| 5 years | -90.6% | +76.0% |
Key statistics
- Market value
- $1.74B
- Price / sales
- 29.3
- 52-week range
- $8.04 to $17.84
- Next report
- Nov 5, 2026 (estimated)
About Intellia Therapeutics
Intellia Therapeutics develops CRISPR-based gene-editing therapies for genetic diseases.
Sector: Health Care
More on Intellia Therapeutics
- Financials: revenue, earnings and segmentsRevenue +17% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $962.19 today
No forecast, no recommendation. This page describes Intellia Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.